News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Jose C. Tapia: Looking forward to ASCOGU25
Jose C. Tapia/X
Feb 12, 2025, 07:29

Jose C. Tapia: Looking forward to ASCOGU25

Jose C. Tapia, Medical Oncologist at Velindre University NHS Trust, shared a post on X:

“Looking forward to ASCOGU25:

  • Prostate: Combos with iPARP- and Lu- , EZH2.
  • Urothelial: Updates, HER-2, FGFR3, and high-risk UTUC.
  • Renal: Updates, UO3B, KIM-1, HIF-2 inh and MET inh.
  • Testicular: RPLND advanced Seminoma.
  • Penile: IO-chemo for advanced Ca.

Jose C. Tapia: Looking forward to ASCOGU25

ASCOGU25 cancer fight against cancer Global fight against cancer Jose C. Tapia MedOnc OncoDaily Oncology RPLND UTUC Velindre University NHS Trust
Special Coverage
OncoDaily Pulse
Feb 12, 2025, 11:30
ACT for Children: Tackling Inequities in Childhood Cancer Through Unique Global Collaboration
Feb 12, 2025, 11:25
Breast Cancer: Symptoms Causes, Stages, Diagnosis and Treatment
Oncolibrary
Feb 12, 2025, 10:41
New Paper Alert: Survival and Treatment Outcomes of Pancreatic Cancer in Armenia: A 12-Year Retrospective Study
Blog
Feb 12, 2025, 10:04
International Cancer Foundation's first Regional Partners Forum
Blog
Feb 12, 2025, 10:03
POHER Scholar alum Martha Kamanga at the Levy Mwanawasa University Teaching Hospital
Insight
Feb 12, 2025, 09:49
Nathan Cherny on the ongoing disparities in access to essential cancer medicines - ESMO
Science
Feb 12, 2025, 09:47
Suman Kumar Vodnala: A novel three-gene "MANAscore" algorithm for lung cancer and melanoma patients
Blog
Feb 12, 2025, 09:40
Yvonne Diaz at the Pistoia Alliance's annual London Conference - Oncogene Cancer Research
Blog
Feb 12, 2025, 09:37
Gertjan Rasschaert: Immunosensitivity cuts across mismatch repair status in colorectal cancer
Science
Feb 12, 2025, 09:32
Evolving field of immunotherapy: pioneering new paths in SCLC by Antonious Ziad Hazim et al.
Insight
Feb 12, 2025, 09:31
Results from phase 3 CEPHEUS study are out - MSK Department of Medicine
Science
Feb 12, 2025, 09:24
High-purity CTC RNA sequencing identifies prognostic prostate cancer phenotypes by Marina Sharifi et al.